DENTSPLY SIRONA Inc. (XRAY)
Data as of , from SEC Form 4 filings.
See up to 3 months of XRAY. The 7-day demo opens the 1M and 3M ranges and puts XRAY on your watchlist.
Start 7-day demoLatest XRAY insider trades
Jonathan Jay Mazelsky - DirectorOpen-market purchase$101K
Clyde Hosein - DirectorOpen-market purchase$65K
About DENTSPLY SIRONA Inc. (XRAY)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
- CHARLOTTE, NC
- 14,000
- 1983
- XNAS
XRAY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 131,537 | |
| Tax withholding / forfeiture | 1 | 802 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
XRAY insider transactions (Form 4)
49124 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Daniel T. Scavilla - Officer | Grant or award | Common Stock | 145,089 footnote F1 | $0.00 | - | |
| Daniel T. Scavilla - Officer | Grant or award | Stock Option (Right to Buy) | 2,066,600 | $0.00 | - | |
| ||||||
 Robert Anthony Johnson - Officer | Tax withholding / forfeiture | Common Stock | 4,481 footnote F2 | $13.30 | $60K | |
| Robert Anthony Johnson - Officer | Tax withholding / forfeiture | Common Stock | 1,026 footnote F2 | $13.44 | $14K | |
| Robert Anthony Johnson - Officer | Tax withholding / forfeiture | Common Stock | 3,229 footnote F1 | $13.30 | $43K | |
| ||||||
 Andrea L. Frohning - Officer | Tax withholding / forfeiture | Common Stock | 2,990 footnote F1 | $13.30 | $40K | |
| Andrea L. Frohning - Officer | Tax withholding / forfeiture | Common Stock | 1,977 footnote F2 | $13.30 | $26K | |
| Andrea L. Frohning - Officer | Tax withholding / forfeiture | Common Stock | 690 footnote F2 | $13.44 | $9K | |
| ||||||
| Kevin Czerney - Officer | Tax withholding / forfeiture | Common Stock | 527 footnote F1 | $13.30 | $7K | |
| Kevin Czerney - Officer | Tax withholding / forfeiture | Common Stock | 1,197 footnote F2 | $13.30 | $16K | |
| Kevin Czerney - Officer | Tax withholding / forfeiture | Common Stock | 328 footnote F2 | $13.44 | $4K | |
| ||||||
| Gregory T. Lucier - Director | Open-market purchase | Common Stock | 27,555 footnote F1 | $14.25 footnote F2 | $393K | |
| Gregory T. Lucier - Director | Open-market purchase | Common Stock | 22,445 footnote F1 | $14.03 footnote F3 | $315K | |
| ||||||
| Robert Anthony Johnson - Officer | Grant or award | Common Stock | 9,599 footnote F1 | $0.00 | - | |
| ||||||
| Andrea L. Frohning - Officer | Grant or award | Common Stock | 8,861 footnote F1 | $0.00 | - | |
| ||||||
| Kevin Czerney - Officer | Grant or award | Common Stock | 1,478 footnote F1 | $0.00 | - | |
| ||||||
| James D. Forbes - Director | Open-market purchase | Common Stock | 5,000 | $13.47 | $67K | |
| Daniel T. Scavilla - Officer | Tax withholding / forfeiture | Common Stock | 1,194 footnote F1 | $13.14 | $16K | |
| ||||||
| Donald Zurbay - Director | Grant or award | Common Stock | 6,871 footnote F1 | $0.00 | - | |
| ||||||
 Janet S. Vergis - Director | Grant or award | Common Stock | 200.9 footnote F1 | $0.00 | - | |
| ||||||
| Leslie F. Varon - Director | Grant or award | Common Stock | 198.14 footnote F1 | $0.00 | - | |
| ||||||
| Daniel T. Scavilla - Officer | Grant or award | Common Stock | 245.82 footnote F1 | $0.00 | - | |
| ||||||
| Jonathan Jay Mazelsky - Director | Grant or award | Common Stock | 395.16 footnote F1 | $0.00 | - | |
| Jonathan Jay Mazelsky - Director | Grant or award | Phantom Stock (Directors' Deferred Compensation) DDC | 153.7 footnote F3 | $12.22 | $2K | |
| ||||||
| Gregory T. Lucier - Director | Grant or award | Common Stock | 341.11 footnote F1 | $0.00 | - | |
| ||||||
| Robert Anthony Johnson - Officer | Grant or award | Common Stock | 641.63 footnote F1 | $0.00 | - | |
| Robert Anthony Johnson - Officer | Grant or award | Phantom Stock (Supplemental Executive Retirement Plan) SERP | 40.22 footnote F4 | $12.22 | $491 | |
| ||||||
| Clyde Hosein - Director | Grant or award | Common Stock | 355.05 footnote F1 | $0.00 | - | |
| ||||||
| Betsy D. Holden - Director | Grant or award | Common Stock | 710.96 footnote F1 | $0.00 | - | |
| ||||||
 Brian T. Gladden - Director | Grant or award | Common Stock | 314.96 footnote F1 | $0.00 | - | |
| ||||||
| Andrea L. Frohning - Officer | Grant or award | Common Stock | 392.39 footnote F1 | $0.00 | - | |
| Andrea L. Frohning - Officer | Grant or award | Phantom Stock (Supplemental Executive Retirement Plan) SERP | 22.73 footnote F3 | $12.22 | $278 | |
| ||||||
 Willie A. Deese - Director | Grant or award | Common Stock | 201.51 footnote F1 | $0.00 | - | |
| ||||||
| Kevin Czerney - Officer | Grant or award | Common Stock | 262.72 footnote F1 | $0.00 | - | |
| Kevin Czerney - Officer | Grant or award | Phantom Stock (Dentsply Supplemental Savings Plan) DSSP | 4.05 footnote F5 | $12.22 | $50 | |
| Kevin Czerney - Officer | Grant or award | Phantom Stock (Supplemental Executive Retirement Plan) SERP | 45.13 | $12.22 | $551 | |
| ||||||
| Michael J. Barber - Director | Grant or award | Common Stock | 245.82 footnote F1 | $0.00 | - | |
| ||||||
| Jonathan Jay Mazelsky - Director | Grant or award | Phantom Stock (Directors' Deferred Compensation) DDC | 2,638 | $11.37 | $30K | |
| Robert Anthony Johnson - Officer | Tax withholding / forfeiture | Common Stock | 293 footnote F1 | $11.34 | $3K | |
| Robert Anthony Johnson - Officer | Tax withholding / forfeiture | Common Stock | 8,737 footnote F1 | $11.34 | $99K | |
| ||||||
| Leslie F. Varon - Director | Open-market purchase | Common Stock | 9,337 | $10.71 | $100K | |
| Robert Anthony Johnson - Officer | Grant or award | Stock Option (Right to Buy) | 417,200 | $0.00 | - | |
| Robert Anthony Johnson - Officer | Grant or award | Stock Option (Right to Buy) | 361,700 | $0.00 | - | |
| Gregory T. Lucier - Director | Grant or award | Common Stock | 310.4 footnote F1 | $0.00 | - | |
| Gregory T. Lucier - Director | Gift | Stock Option (Right to Buy) | 17,200 | $0.00 | - | |
| Gregory T. Lucier - Director | Gift | Stock Option (Right to Buy) | 17,200 | $0.00 | - | |
| ||||||
| Kevin Czerney - Officer | Grant or award | Common Stock | 233.91 footnote F1 | $0.00 | - | |
| Kevin Czerney - Officer | Grant or award | Phantom Stock (Supplemental Executive Retirement Plan) SERP | 45.46 footnote F4 | $11.98 | $545 | |
| Kevin Czerney - Officer | Grant or award | Phantom Stock (Dentsply Supplemental Savings Plan) DSSP | 4.45 footnote F4 | $11.98 | $53 | |
| ||||||
Item 2.02, 9.01
Item 9.01
Item 5.02, 7.01, 9.01
Item 5.07
XRAY insider trading FAQ
What is the latest insider trade for XRAY?
DENTSPLY SIRONA Inc. (XRAY) had 3 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for XRAY runs to 124 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying XRAY stock?
No insider purchases of XRAY were filed in the last 90 days. 15 purchases are on record for this company.
How many insiders are selling XRAY stock?
No insider sales of XRAY were filed in the last 90 days.
Where can I see XRAY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects XRAY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jonathan Jay Mazelsky view on EDGAR
- - John C. Fortson view on EDGAR
- - Andrea L. Frohning view on EDGAR
- - Jonathan Jay Mazelsky view on EDGAR
- - Jonathan Jay Mazelsky view on EDGAR
- - Clyde Hosein view on EDGAR
- - Brian P. McKeon view on EDGAR
- - Brian T. Gladden view on EDGAR
- - Jonathan Jay Mazelsky view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where XRAY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow XRAY with a 7-day demo
- XRAY on your watchlist
- Every XRAY Form 4 filing on record
- Up to 3 months of XRAY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
